Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Epelbaum

Showing results (151-160 of 199) with videos related to

Pageof 20
Sort By:
Journal of Neuroendocrinology|August 1, 1995
Effects of chronic octreotide treatment on GH secretory dynamics and tumor growth in rats bearing an ectopic somatotroph (GC) tumorF Mounier, M T Bluet-Pajot, C Viollet, et al.
Endocrinology|September 18, 2007
Leptin sensitivity in the developing rat hypothalamusA-S Carlo, M Pyrski, C Loudes, et al.
Neuroscience|January 1, 1991
Regional distribution of somatostatin binding sites in the human hypothalamus: a quantitative autoradiographic studyM Najimi, D Jordan, F Chigr, et al.
Peptides|January 1, 1990
125I-[Tyr0,D-Trp8]somatostatin-14 binding sites in the locus coeruleus of the rat are located on both ascending and descending projecting noradrenergic cellsJ Epelbaum, M T Bluet-Pajot, C Llorens-Cortes, et al.
Research Publications - Association for Research in Nervous and Mental Disease|January 1, 1978
Neuroendocrine organization of growth hormone regulationJ B Martin, P Brazeau, G S Tannenbaum, et al.
Experimental Gerontology|July 18, 2013
Calorie restriction and resveratrol supplementation prevent age-related DNA and RNA oxidative damage in a non-human primateJ Marchal, A Dal-Pan, J Epelbaum, et al.
Annales De Biologie Clinique|July 27, 2001
[Neuroendocrine aging]J Epelbaum, M H Bassant, M T Bluet-Pajot, et al.
Hormone Research|January 1, 1992
Resistance to somatostatin (SRIH) analog therapy in acromegaly. Re-evaluation of the correlation between the SRIH receptor status of the pituitary tumor and the in vivo inhibition of GH secretion in response to SRIH analogJ Bertherat, P Chanson, D Dewailly, et al.
Journal of Neurochemistry|February 1, 1994
Influence of region-specific alterations of neuropeptidase content on the catabolic fates of neuropeptides in Alzheimer's diseaseC Ichai, N Chevallier, P Delaere, et al.
Neuropharmacology|April 2, 2003
Biological activity of somatostatin receptors in GC rat tumour somatotrophs: evidence with sst1-sst5 receptor-selective nonpeptidyl agonistsD Cervia, P Zizzari, B Pavan, et al.
Pageof 20

Showing results (151-160 of 199) with videos related to

Sort By:
Pageof 20
Journal of Neuroendocrinology|August 1, 1995
Effects of chronic octreotide treatment on GH secretory dynamics and tumor growth in rats bearing an ectopic somatotroph (GC) tumorF Mounier, M T Bluet-Pajot, C Viollet, et al.
Endocrinology|September 18, 2007
Leptin sensitivity in the developing rat hypothalamusA-S Carlo, M Pyrski, C Loudes, et al.
Neuroscience|January 1, 1991
Regional distribution of somatostatin binding sites in the human hypothalamus: a quantitative autoradiographic studyM Najimi, D Jordan, F Chigr, et al.
Peptides|January 1, 1990
125I-[Tyr0,D-Trp8]somatostatin-14 binding sites in the locus coeruleus of the rat are located on both ascending and descending projecting noradrenergic cellsJ Epelbaum, M T Bluet-Pajot, C Llorens-Cortes, et al.
Research Publications - Association for Research in Nervous and Mental Disease|January 1, 1978
Neuroendocrine organization of growth hormone regulationJ B Martin, P Brazeau, G S Tannenbaum, et al.
Experimental Gerontology|July 18, 2013
Calorie restriction and resveratrol supplementation prevent age-related DNA and RNA oxidative damage in a non-human primateJ Marchal, A Dal-Pan, J Epelbaum, et al.
Annales De Biologie Clinique|July 27, 2001
[Neuroendocrine aging]J Epelbaum, M H Bassant, M T Bluet-Pajot, et al.
Hormone Research|January 1, 1992
Resistance to somatostatin (SRIH) analog therapy in acromegaly. Re-evaluation of the correlation between the SRIH receptor status of the pituitary tumor and the in vivo inhibition of GH secretion in response to SRIH analogJ Bertherat, P Chanson, D Dewailly, et al.
Journal of Neurochemistry|February 1, 1994
Influence of region-specific alterations of neuropeptidase content on the catabolic fates of neuropeptides in Alzheimer's diseaseC Ichai, N Chevallier, P Delaere, et al.
Neuropharmacology|April 2, 2003
Biological activity of somatostatin receptors in GC rat tumour somatotrophs: evidence with sst1-sst5 receptor-selective nonpeptidyl agonistsD Cervia, P Zizzari, B Pavan, et al.
Pageof 20